Capricor Therapeutics, Inc. (CAPR) Social Stream



Capricor Therapeutics, Inc. (CAPR): $4.76

0.08 (-1.65%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add CAPR to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#237 of 348

in industry

CAPRICOR THERAPEUTICS INC (CAPR) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering CAPR.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-10 2 $14 $12 $13 $4.6 182.61%
2022-08-11 2 $18 $12 $15 $4.6 226.09%
2023-05-15 3 $18 $12 $15 $4.6 226.09%
2023-10-02 2 $18 $15 $16.5 $4.6 258.7%
2023-10-04 3 $40 $15 $27.5 $4.6 497.83%
2023-11-16 3 $40 $12.001 $22.333 $4.6 385.5%

The Trend in the Analyst Price Target


Over the past 22 months, CAPR's average price target has gone up $7.33.

CAPR reports an average of 429.53% for its upside potential over the past 35 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-10-02 2 18 15.000 16.500 2.97 455.56%
2023-10-04 3 40 15.000 27.500 2.84 868.31%
2023-10-04 2 40 15.000 27.500 2.84 868.31%
2023-10-20 3 40 12.001 22.333 2.76 709.17%
2023-11-16 3 40 12.001 22.333 3.08 625.1%

CAPR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 3 0 0 0 0 3

The Trend in the Broker Recommendations


CAPR's average broker recommendation rating improved by 1 over the prior 25 months.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • CAPR has a greater number of analysts covering the stock than 33.33% of all US stocks.
  • In the context of all US stocks, CAPRICOR THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 632.89% of them.
  • To contextualize these metrics, consider that out of all US stocks, CAPRICOR THERAPEUTICS INC's variance in analysts' estimates is lower than -283.48% of them.
  • CAPRICOR THERAPEUTICS INC's average analyst price target is greater than 511.78% of stocks in the micro market cap category.

In the Pharmaceutical Products industry, KTRA, ATXI, and LPTX are the three stocks most similar to CAPRICOR THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.

Is CAPR a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!